Pediatrix Medical Group (NYSE:MD) Sets New 1-Year High – Time to Buy?

Pediatrix Medical Group, Inc. (NYSE:MD)’s stock price hit a new 52-week high on Wednesday. The company traded as high as $31.62 and last traded at $31.5640, with a volume of 20,867 shares traded. The stock had previously closed at $30.60.

Wall Street Analysts Forecast Growth

MD has been the subject of a number of recent research reports. Weiss Ratings upgraded shares of Pediatrix Medical Group from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, September 9th. Truist Financial increased their target price on Pediatrix Medical Group from $28.00 to $31.00 and gave the stock a “hold” rating in a research report on Friday, October 30th. UBS Group increased their target price on Pediatrix Medical Group from $25.00 to $28.00 and gave the stock a “neutral” rating in a research report on Thursday, August 6th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $25.00 price target on shares of Pediatrix Medical Group in a report on Wednesday, August 5th. Finally, Jefferies Financial Group cut Pediatrix Medical Group from a “buy” rating to a “hold” rating and lifted their price target for the company from $27.00 to $28.00 in a research report on Wednesday, August 19th. One analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $27.20.

Pediatrix Medical Group Stock Performance

The company’s fifty day simple moving average is $27.09 and its 200 day simple moving average is $23.95. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 0.47. The stock has a market capitalization of $2.53 billion, a P/E ratio of 17.58 and a beta of 0.62.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings data on Thursday, October 29th. The company reported $0.72 earnings per share for the quarter, topping the consensus estimate of $0.65 by $0.07. The company had revenue of $501.37 million for the quarter, compared to analysts’ expectations of $498.18 million. Pediatrix Medical Group had a net margin of 7.66% and a return on equity of 20.12%. Pediatrix Medical Group’s revenue for the quarter was up 1.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.67 earnings per share. As a group, sell-side analysts forecast that Pediatrix Medical Group, Inc. will post 2.17 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in MD. Choreo LLC grew its holdings in shares of Pediatrix Medical Group by 5.7% during the 3rd quarter. Choreo LLC now owns 8,361 shares of the company’s stock worth $215,000 after acquiring an additional 448 shares during the period. Keybank National Association OH raised its position in shares of Pediatrix Medical Group by 2.0% in the 1st quarter. Keybank National Association OH now owns 22,941 shares of the company’s stock worth $491,000 after acquiring an additional 458 shares in the last quarter. Nisa Investment Advisors LLC raised its position in shares of Pediatrix Medical Group by 3.3% in the 3rd quarter. Nisa Investment Advisors LLC now owns 19,131 shares of the company’s stock worth $492,000 after acquiring an additional 605 shares in the last quarter. Hohimer Wealth Management LLC lifted its stake in shares of Pediatrix Medical Group by 5.4% in the 3rd quarter. Hohimer Wealth Management LLC now owns 12,714 shares of the company’s stock valued at $327,000 after purchasing an additional 655 shares during the period. Finally, State of Wyoming lifted its stake in shares of Pediatrix Medical Group by 4.5% in the 3rd quarter. State of Wyoming now owns 24,525 shares of the company’s stock valued at $631,000 after purchasing an additional 1,060 shares during the period. 97.71% of the stock is owned by hedge funds and other institutional investors.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc provides specialized physician-led healthcare services for women, infants and children. The company’s clinical offerings include neonatal and perinatal care, maternal-fetal medicine, pediatric medical subspecialties, pediatric hospitalist services and related services delivered in partnership with hospitals and healthcare systems.

Pediatrix-affiliated physicians and advanced practice providers generally work in hospital-based settings, including neonatal intensive care units, delivery rooms, pediatric units and outpatient practices.